William James Adams, Senior Officer at Response Biomed, holds 155.82K shares in NervGen Pharma (Ticker: NGENF), holds 47.50K shares in Response Biomed (Ticker: TSE:RBM). Most recently, William James Adams Bought ― shares of NervGen Pharma on Mar 29, 2024 for an estimated value of 103.56K.